RIO

7,088

+2.1%↑

GLEN

561.4

-1.2%↓

CRH

107.25

+4.47%↑

ANTO

3,490

+4.4%↑

S32

234

+4.46%↑

RIO

7,088

+2.1%↑

GLEN

561.4

-1.2%↓

CRH

107.25

+4.47%↑

ANTO

3,490

+4.4%↑

S32

234

+4.46%↑

RIO

7,088

+2.1%↑

GLEN

561.4

-1.2%↓

CRH

107.25

+4.47%↑

ANTO

3,490

+4.4%↑

S32

234

+4.46%↑

RIO

7,088

+2.1%↑

GLEN

561.4

-1.2%↓

CRH

107.25

+4.47%↑

ANTO

3,490

+4.4%↑

S32

234

+4.46%↑

RIO

7,088

+2.1%↑

GLEN

561.4

-1.2%↓

CRH

107.25

+4.47%↑

ANTO

3,490

+4.4%↑

S32

234

+4.46%↑

Search

Elementis PLC

Открыт

153 1.86

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

149.4

Макс.

153.8

Ключевые показатели

By Trading Economics

Доход

92M

27M

Продажи

-17M

291M

P/E

Средняя по отрасли

18.65

32.651

Прибыль на акцию

0.068

Дивидендная доходность

2.89

Рентабельность продаж

9.392

Сотрудники

989

EBITDA

-23M

50M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+36.09% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.89%

2.88%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-88M

849M

Предыдущая цена открытия

151.14

Предыдущая цена закрытия

153

Elementis PLC График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

31 мар. 2026 г., 23:31 UTC

Популярные акции

Stocks to Watch: Nike, RH, NCino

31 мар. 2026 г., 22:35 UTC

Отчет

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 апр. 2026 г., 00:00 UTC

Приобретения, слияния, поглощения

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 мар. 2026 г., 23:50 UTC

Приобретения, слияния, поглощения

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 мар. 2026 г., 23:43 UTC

Обсуждения рынка

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 мар. 2026 г., 23:33 UTC

Обсуждения рынка
Главные новостные события

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 мар. 2026 г., 23:21 UTC

Отчет

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 мар. 2026 г., 23:14 UTC

Обсуждения рынка
Отчет

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 мар. 2026 г., 23:12 UTC

Обсуждения рынка

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 мар. 2026 г., 22:36 UTC

Отчет

China Vanke 2025 Loss Widens >000002.SZ

31 мар. 2026 г., 22:36 UTC

Отчет

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 мар. 2026 г., 22:36 UTC

Отчет

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 мар. 2026 г., 22:36 UTC

Отчет

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 мар. 2026 г., 22:36 UTC

Отчет

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 мар. 2026 г., 21:46 UTC

Приобретения, слияния, поглощения

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 мар. 2026 г., 21:36 UTC

Обсуждения рынка

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 мар. 2026 г., 21:35 UTC

Отчет

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 мар. 2026 г., 21:35 UTC

Отчет

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 мар. 2026 г., 21:35 UTC

Отчет

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 мар. 2026 г., 21:33 UTC

Приобретения, слияния, поглощения

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 мар. 2026 г., 21:33 UTC

Отчет

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 мар. 2026 г., 21:32 UTC

Отчет

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 мар. 2026 г., 21:28 UTC

Отчет

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 мар. 2026 г., 21:26 UTC

Отчет

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 мар. 2026 г., 21:25 UTC

Отчет

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 мар. 2026 г., 21:24 UTC

Обсуждения рынка
Отчет

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 мар. 2026 г., 21:22 UTC

Отчет

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 мар. 2026 г., 21:22 UTC

Отчет

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 мар. 2026 г., 21:21 UTC

Отчет

Nike's Digital Channel Still Too Promotional, CFO Says

31 мар. 2026 г., 21:20 UTC

Отчет

Nike CEO: Converse Remains Important to Portfolio

Сравнение c конкурентами

Изменение цены

Elementis PLC Прогноз

Целевая цена

By TipRanks

36.09% рост

Прогноз на 12 месяцев

Средняя 202.5 GBX  36.09%

Максимум 210 GBX

Минимум 190 GBX

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Elementis PLC на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

4 ratings

4

Покупка

0

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Elementis PLC

Elementis plc operates as a specialty chemical company in the United Kingdom, rest of Europe, North America, and internationally. It operates in two segments, Performance Specialties and Personal Care. The Performance Specialties segment engages in the production of rheological modifiers and additives for decorative and industrial coatings; and production and supply of talc for use in plastics, coatings, technical ceramics, and paper sectors. The Personal Care segment provides rheological modifiers and compounded products, including active ingredients for antiperspirants (AP) deodorants for personal care manufacturers. The company offers personal care products for antiperspirants, color cosmetics, and skin care applications; and performance specialties products for architectural coatings, adhesives, sealants and construction additives, and talc applications. Elementis plc was founded in 1844 and is headquartered in London, the United Kingdom.
help-icon Live chat